Tom Burt

Tom Burt

Director/Board Member at
Synthace Ltd.
47 year
Finance
Consumer Services
Health Technology

Profile

Thomas Henry Burt is currently a Director at Synthace Ltd., a Partner at Sofinnova Partners SAS, and a Member of the Association of Engineering Doctorates.
He previously worked as an Investment Director at Ares Life Sciences LP, an Investment Director at Novo Holdings Ltd., an Associate at Piper Sandler Ltd., and an Associate at Novo Principal Investments.
He also served as a Non-Executive Director at Redx Pharma Plc from 2020 to 2023 and as an Assistant Director at Peel Hunt LLP from 2015 to 2017.
Burt holds a graduate degree from the University of Birmingham and undergraduate and doctorate degrees from University College London.

Tom Burt active positions

CompaniesPositionStart
Private Equity Investor 01/06/2017
Director/Board Member 12/11/2021
Association of Engineering Doctorates
Corporate Officer/Principal -

Former positions of Tom Burt

CompaniesPositionEnd
REDX PHARMA LTD Director/Board Member 01/09/2023
Analyst-Equity 28/04/2017
Private Equity Analyst 31/01/2013
Chief Investment Officer -
Chief Investment Officer -
See the detail of Tom Burt's experience

Training of Tom Burt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

36

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Finance

Consumer Services

Consumer Services

Finance

Finance

Health Technology

Finance

Finance

Technology Services

Association of Engineering Doctorates